Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

Cemiplimab

Index Cemiplimab

Cemiplimab (REGN-2810) is a monoclonal antibody under development as a drug for the treatment of squamous cell skin cancer, myeloma, and lung cancer. [1]

5 relations: Lung cancer, Monoclonal antibody, Multiple myeloma, Programmed cell death protein 1, Squamous cell skin cancer.

Lung cancer

Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung.

New!!: Cemiplimab and Lung cancer · See more »

Monoclonal antibody

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell.

New!!: Cemiplimab and Monoclonal antibody · See more »

Multiple myeloma

Multiple myeloma, also known as plasma cell myeloma, is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies.

New!!: Cemiplimab and Multiple myeloma · See more »

Programmed cell death protein 1

Programmed cell death protein 1, also known as PD-1 and CD279 (cluster of differentiation 279), is a protein found on the surface of cells that has a role in regulating the immune system's response to the cells of the human body by down-regulating the immune system and promoting self tolerance by suppressing T cell inflammatory activity.

New!!: Cemiplimab and Programmed cell death protein 1 · See more »

Squamous cell skin cancer

Squamous-cell skin cancer, also known as cutaneous squamous-cell carcinoma (cSCC), is one of the main types of skin cancer along with basal cell cancer, and melanoma.

New!!: Cemiplimab and Squamous cell skin cancer · See more »

Redirects here:

REGN2810.

References

[1] https://en.wikipedia.org/wiki/Cemiplimab

OutgoingIncoming
Hey! We are on Facebook now! »